Has the National Fall in Smoking Rates in Ireland Been Replicated in Cancer Patients? A 5-Year Report

Patricia Fitzpatrick, Nancy Bhardwaj, Ailsa Lyons, Kirsten Doherty, Kate Frazer, Amanda McCann, Vikram Niranjan, Shiraz Syed and Patricia Fox
Additional contact information
Patricia Fitzpatrick: School of Public Health, Physiotherapy & Sports Science, University College Dublin, D04 V1W8 Dublin, Ireland
Nancy Bhardwaj: School of Public Health, Physiotherapy & Sports Science, University College Dublin, D04 V1W8 Dublin, Ireland
Ailsa Lyons: Department of Preventive Medicine & Health Promotion, St. Vincent’s University Hospital, D04 T6F4 Dublin, Ireland
Kirsten Doherty: Department of Preventive Medicine & Health Promotion, St. Vincent’s University Hospital, D04 T6F4 Dublin, Ireland
Kate Frazer: School of Nursing, Midwifery and Health Systems, University College Dublin, D04 V1W8 Dublin, Ireland
Amanda McCann: Conway Institute of Biomolecular and Biomedical Research, University College Dublin, D04 V1W8 Dublin, Ireland
Vikram Niranjan: School of Public Health, Physiotherapy & Sports Science, University College Dublin, D04 V1W8 Dublin, Ireland
Shiraz Syed: Department of Preventive Medicine & Health Promotion, St. Vincent’s University Hospital, D04 T6F4 Dublin, Ireland
Patricia Fox: School of Nursing, Midwifery and Health Systems, University College Dublin, D04 V1W8 Dublin, Ireland

IJERPH, 2022, vol. 19, issue 4, 1-10

Abstract: Smoking among cancer patients leads to poorer outcomes, yet many patients continue smoking. As part of a feasibility study of smoking cessation for cancer patients in Ireland, smoking rates were reviewed. Hospital Inpatient Enquiry (HIPE) data on the smoking status of discharges with a cancer diagnosis (overall, breast, lung, cervical and head and neck cancer) were used (2014–2018). During 2014–2017, current smoking increased for overall (10.5–11.7%) and lung cancer (24.7–27.2%), then decreased to 11.4% and 24.1%, respectively, in 2018. Current smoking increased for cervical during 2014–2018 (11–19.8%) and initially (2014–2016) for head and neck (3–12.7%) cancer, decreasing to 7.6% in 2018; breast cancer was stable at 6 ± 0.6%. These rates are lower than the Irish (23–20%) and European (29% (average)) general population. During 2014–2017, past smoking increased among overall (15.2–21%) and specific cancers, which was lower than the Irish general population (23–28%). Current smoking was highest among 50–59-year-olds (14–16%), which contrasts with the Irish general population (24–35 years at 32–28%). HIPE data are subject to potential duplicate episodes of care and under-documentation of smoking. However, trend analysis is useful, as these limitations should be stable. Rates remain high; therefore, robust documentation and smoking cessation referrals for cancer patients are important.

Keywords: smoking; prevalence; cancer; patients; Ireland (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/4/2348/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/4/2348/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:4:p:2348-:d:752437

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().